# NEURACLE SCIENCE CO.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neuracle-science-co

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.neuracles.com
- Total disclosed funding: $33M
- Latest round: Series C (Jun 13, 2019)
- Investors on record: 9

## About

Founded in 2015 and based in Seoul, South Korea, NEURACLE SCIENCE CO. LTD operates as a biopharmaceutical company that develops pharmaceutical treatments of neurodegenerative diseases. In June 2026, the company raised KRW 2 billion in pre-IPO funding from new investor BNH Investment.

NEURACLE SCIENCE CO. LTD develops treatments for severe neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and neurogenic bowel dysfunction. The company’s research includes candidates like NS101, an antibody currently in clinical development for Alzheimer’s disease and other neurodegenerative conditions, and NS200, which targets colonic motility disorders and neurogenic bowel dysfunction. Their development pipeline also features advanced antibody therapeutics, utilizing proprietary Fc Engineering to enhance drug efficacy. These solutions aim to improve nerve regeneration, synapse formation, and neural environment remodeling.

## Funding rounds

- Series C, Jun 13, 2019, $30M — Shinhan Securities, NH Investment & Securities, BNK Asset Management, IBK Capital, Seven Tree Equity Partners, Ryukyung PSG Asset Management Inc, EUM Private Equity, Brahman Investment
- Series A, May 1, 2016, $3.7M — QUAD Ventures

## Investors

- QUAD Ventures (https://capitalatlas.ai/funds/quad-ventures) — Series A
- Shinhan Securities (https://capitalatlas.ai/funds/shinhan-securities) — Series C
- NH Investment & Securities (https://capitalatlas.ai/funds/nh-investment-securities) — Series C
- BNK Asset Management — Series C
- IBK Capital (https://capitalatlas.ai/funds/ibk-capital) — Series C
- Seven Tree Equity Partners (https://capitalatlas.ai/funds/seven-tree-equity-partners) — Series C
- Ryukyung PSG Asset Management Inc — Series C
- EUM Private Equity (https://capitalatlas.ai/funds/eum-private-equity) — Series C
- Brahman Investment — Series C